Redpin Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
March 25, 2020
Vertical
Gene Therapy
Funding URL
View Funding Page
Funding Amount:
$15,500,000

Company Info
Founders
Elma S. Hawkins
Company Description
Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.
Market
Central Nervous System Diseases
Location
New York, NY, USA
Coinvestors
4BIO Capital, Alexandria Venture Investments, Arkin Bio Ventures, New York Ventures, Takeda Ventures

Links